Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Patent covers selective COX-2 inhibitors for relieving pain, fever and inflammation

Nov. 12, 1998

Radiopharmaceutical for chronic knee synovitis in development at British university

Nov. 11, 1998

European filing announced for Enbrel

Nov. 11, 1998

ATTRACT study establishes efficacy, safety of infliximab in RA patients

Nov. 11, 1998

Cevimeline improves symptoms of xerostomia in animal models, patients with Sjogren's syndrome

Nov. 10, 1998

Knoll's promising new treatment for RA covered in depth at rheumatology congress

Nov. 10, 1998

New series from Agouron with inhibitory activity against MMPs and TNF-alpha production

Nov. 10, 1998

Merck finally reveals chemical structure of lead COX-2 inhibitor

Nov. 6, 1998

Eisai to collaborate with Toyama in development, marketing of DMARD

Nov. 5, 1998

Inhibitors of cell adhesion with antiinflammatory activity developed at Japan Energy

Nov. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...